• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immunological and virological findings in a patient with exceptional post-treatment control: a case report (HIV) - The Lancet

Mary Wilson

Well-known member
Available online 27 October 2022

https://doi.org/10.1016/S2352-3018(22)00302-2

NúriaClimentPhD[SUP]a[/SUP][SUP]b[/SUP]* JuanAmbrosioniPhD[SUP]a[/SUP][SUP]b[/SUP]* TàniaGonzálezBSc[SUP]a [/SUP]CristinaXufréPhD[SUP]a [/SUP]MariaCasadellàPhD[SUP]c [/SUP]MarcNoguera-JulianPhD[SUP]b[/SUP][SUP]c[/SUP][SUP]d [/SUP]RogerParedesPhD[SUP]b[/SUP][SUP]c[/SUP][SUP]d [/SUP]MontserratPlanaPhD[SUP]a[/SUP][SUP]b [/SUP]JudithGrau-ExpósitoPhD[SUP]a [/SUP]JosepMallolasPhD[SUP]a[/SUP][SUP]b [/SUP]JoséAlcamíPhD[SUP]a[/SUP][SUP]b[/SUP][SUP]e [/SUP]SonsolesSánchez-PalominoPhD[SUP]a[/SUP][SUP]b[/SUP]† ProfJosé MMiróPhD[SUP]a[/SUP][SUP]b[/SUP]†

Summary

Background

Although antiretroviral therapy (ART) is effective in suppressing viral replication, HIV-1 persists in reservoirs and rebounds after ART has been stopped. However, a very few people (eg, elite and post-treatment controllers) are able to maintain viral loads below detection limits without ART, constituting a realistic model for long-term HIV remission. Here, we describe the HIV control mechanisms of an individual who showed exceptional post-treatment control for longer than 15 years.

Methods
We report the case of a Hispanic woman aged 59 years with sexually acquired acute HIV infection, who was included in an immune-mediated primary HIV infection trial involving a short course of ciclosporine A, interleukin-2, granulocyte macrophage colony-stimulating factor, and pegylated interferon alfa, followed by analytical treatment interruption. We did the following viral assays: total and integrated HIV-1 DNA in CD4 T cells and rectal tissue, quantitative viral outgrowth assay, HIV-1 infectivity in peripheral blood mononuclear cells and CD4 T-cell cultures and viral inhibitory activity by natural killer (NK) and CD8 T cells. NK and T-cell phenotypes were determined by flow cytometry. HLA, killer cell immunoglobulin-like receptors, Δ32CCR5, and NKG2C alleles were genotyped.

Findings
After ART and immunomodulatory treatment, the person maintained undetectable plasma viral load for 15 years. HIV-1 subtype was CFR_02AG, CCR5-tropic. We found progressive reductions in viral reservoir during the 15-year treatment interruption: total HIV DNA (from 4573·50 copies per 10[SUP]6[/SUP] CD4 T cells to 95·33 copies per 10[SUP]6[/SUP] CD4 T cells) and integrated DNA (from 85·37 copies per 10[SUP]6[/SUP] CD4 T cells to 5·25 copies per 10[SUP]6[/SUP] CD4 T cells). Viral inhibition assays showed strong inhibition of in vitro HIV replication in co-cultures of CD4 T cells with autologous NK or CD8 T cells at 1:2 ratio (75% and 62%, respectively). Co-cultures with NK and CD8 T cells resulted in 93% inhibition. We detected higher-than-reference levels of both NKG2C-memory-like NK cells (46·2%) and NKG2C γδ T cells (64·9%) associated with HIV-1 control.

Interpretation
We described long-term remission in a woman aged 59 years who was treated during primary HIV infection and has maintained undetectable viral load for 15 years without ART. Replication-competent HIV-1 was isolated. NKG2C-memory-like NK cells and γδ T cells were associated with the control viral replication. Strategies promoting these cells could bring about long-term HIV remission.

https://www.sciencedirect.com/science/article/pii/S2352301822003022?dgcid=coauthor
 
Back
Top Bottom